Aytu Biopharma annual gross margin
2020
2021
2022
2023
2024
2025
Aytu Biopharma Gross Margin Growth & History (AYTU)
Aytu Biopharma's gross margin was 69.04% for fiscal 2025.
View full Aytu Biopharma company overviewAytu Biopharma annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-06-30 | 69.04% | −6.21 pp |
| 2024 | 2024-06-30 | 75.26% | +13.21 pp |
| 2023 | 2023-06-30 | 62.04% | +7.96 pp |
| 2022 | 2022-06-30 | 54.08% | +9.59 pp |
| 2021 | 2021-06-30 | 44.49% | −25.54 pp |
| 2020 | 2020-06-30 | 70.03% | — |
Aytu Biopharma quarterly gross margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2026 | 2026-03-31 | 61.23% | −8.17 pp |
| Q2 2026 | 2025-12-31 | 63.46% | −3.03 pp |
| Q1 2026 | 2025-09-30 | 66.14% | −6.17 pp |
| Q4 2025 | 2025-06-30 | 67.75% | −7.98 pp |
| Q3 2025 | 2025-03-31 | 69.40% | −4.47 pp |
| Q2 2025 | 2024-12-31 | 66.49% | −11.40 pp |
| Q1 2025 | 2024-09-30 | 72.31% | −0.87 pp |
| Q4 2024 | 2024-06-30 | 75.73% | +15.33 pp |
| Q3 2024 | 2024-03-31 | 73.88% | +17.82 pp |
| Q2 2024 | 2023-12-31 | 77.89% | +12.09 pp |
| Q1 2024 | 2023-09-30 | 73.18% | +7.97 pp |
| Q4 2023 | 2023-06-30 | 60.41% | +6.33 pp |
| Q3 2023 | 2023-03-31 | 56.06% | +3.63 pp |
| Q2 2023 | 2022-12-31 | 65.81% | +12.62 pp |
| Q1 2023 | 2022-09-30 | 65.20% | +8.32 pp |
| Q4 2022 | 2022-06-30 | 54.07% | +5.96 pp |
| Q3 2022 | 2022-03-31 | 52.42% | +55.78 pp |
| Q2 2022 | 2021-12-31 | 53.18% | −5.55 pp |
| Q1 2022 | 2021-09-30 | 56.88% | −13.06 pp |
| Q4 2021 | 2021-06-30 | 48.12% | — |
| Q3 2021 | 2021-03-31 | −3.35% | — |
| Q2 2021 | 2020-12-31 | 58.73% | — |
| Q1 2021 | 2020-09-30 | 69.95% | — |
Aytu Biopharma gross margin trends
Over the last five reported fiscal years, Aytu Biopharma's gross margin decreased from 70.03% to 69.04%, a change of −0.99 percentage points. The latest reported quarter, Q3 2026, shows 61.23%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aytu Biopharma filings at SEC.gov ↗